Where do we draw the line?

Treating prostate cancer: where do we draw the line?

The article by Drs. Lepor and Donin is a provocative look at a timely topic in urologic oncology.[1] There is little debate among experts in the field that we are overtreating prostate cancer at the current time. Studies are ongoing to evaluate active surveillance as an option for low-risk tumors, even in men with very long life expectancies. However, in this review, the authors have overreache...

Where do you draw the line?

Procedural sedation in the emergency department: where do we draw the line?

Mary Jagim is Consultant, Senior Health Care Analyst, E Suite Consulting, Fargo, ND. For correspondence, write: Mary Jagim, RN, BSN, CEN, FAEN, 6030 23rd Street South, Fargo, ND 58104; E-mail: [email protected]. J Emerg Nurs 2007;33:488-91. 0099-1767/$32.00 Copyright n 2007 by the Emergency Nurses Association. doi: 10.1016/j.jen.2007.06.012 A male patient presents to triage in severe pain an...

Replacement of the ascending aorta in bicuspid aortic valve disease: where do we draw the line?

Rogue proliferation versus restorative protection: where do we draw the line for Wnt and forkhead signaling?

BACKGROUND Disease entities such as diabetes, neurodegeneration and cardiovascular disorders affect a significant portion of the world's population. OBJECTIVE Given that cellular survival and longevity in multiple disorders are tied to oxidative stress, apoptotic cell injury and immune system deregulation, the development of robust therapeutic strategies rests heavily upon the ability to bala...